Research Article
Exploration of the Immune-Related Signatures and Immune Infiltration Analysis in Melanoma
Table 1
Baseline characteristics of 470 melanoma patients included in this study.
| | Variables | Count | Percentage (%) |
| | Age () | | | Follow-up (y) | | | Status | | Alive | 259 | (55.11) | | Dead | 211 | (44.89) | | Gender | | Male | 290 | (67.70) | | Female | 180 | (38.30) | | Pathological stage | | I/II NOS | 14 | (2.98) | | Stage 0 | 8 | (1.70) | | Stage I | 76 | (16.1) | | Stage II | 140 | (29.79) | | Stage III | 171 | (36.38) | | Stage IV | 23 | (4.894) | | Unknown | 38 | (8.09) | | AJCC-T | | T0 | 23 | (4.89) | | T1 | 42 | (8.94) | | T2 | 78 | (16.60) | | T3 | 90 | (19.15) | | T4 | 153 | (32.55) | | Tis | 8 | (1.70) | | TX | 47 | (10.00) | | Unknown | 29 | (6.17) | | AJCC-N | | N0 | 235 | (50.00) | | N1 | 74 | (15.74) | | N2 | 49 | (10.43) | | N3 | 55 | (11.70) | | NX | 36 | (7.66) | | Unknown | 21 | (4.47) | | AJCC-M | | M0 | 418 | (88.94) | | M1 | 24 | (5.11) | | Unknown | 28 | (5.96) | | Grade | | G1 | — | — | | G2 | — | — | | G3 | — | — | | G4 | — | — | | Unknown | 1053 | (100) | | Risk score | | Low | 227 | (48.30) | | High | 227 | (48.30) | | Unknown | 16 | (3.40) |
|
|
Abbreviations: TCGA: The Cancer Genome Atlas; AJCC: American Joint Committee on Cancer; TAIG: tumor-associated immune genes.
|
